SPR® Therapeutics Unveils Long-term Data on SPRINT® PNS and Initial MONARCH™ Trial Update
15 juil. 2024 09h05 HE
|
SPR Therapeutics, Inc.
SPR Therapeutics announced the presentation of five abstracts at the ASPN Annual Conference including four-year data on SPRINT PNS.
SPR® Therapeutics Recognized as a Top Workplace in Northeast Ohio for the Third Year in a Row
23 juin 2024 10h00 HE
|
SPR Therapeutics, Inc.
Medical Device Leader SPR Therapeutics again named a Top Workplace in Northeast Ohio
New Publication Reviewing Percutaneous PNS in the Management of Chronic Pain Highlights Consistent, Sustained Relief of Pain Across Multiple Targets
11 juin 2024 12h47 HE
|
SPR Therapeutics, Inc.
New Publication on Percutaneous PNS in the Management of Chronic Pain Highlights Consistent, Sustained Relief of Pain Across Multiple Targets
UPDATE - SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee Pain
14 mai 2024 18h33 HE
|
SPR Therapeutics, Inc.
Publication of study provides evidence of the impact of SPRINT PNS in relieving post-operative knee pain after total knee arthroplasty (TKA).
SPR® Therapeutics Announces Publication of Study Providing Evidence of the Impact of SPRINT® PNS Treatment in Relieving Postoperative Knee Pain
13 mai 2024 14h16 HE
|
SPR Therapeutics, Inc.
Publication of study provides evidence of the impact of SPRINT PNS in relieving post-operative knee pain after total knee arthroplasty (TKA).
SPR® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT® PNS System
01 févr. 2024 09h00 HE
|
SPR Therapeutics, Inc.
SPR Therapeutics Announces $85 Million in Additional Funding to Advance Commercial Expansion of SPRINT PNS System.
SPR® Therapeutics Announces Extensive Set of Abstracts to be Shared at North American Neuromodulation Society (NANS) Annual Meeting 2024
16 janv. 2024 09h00 HE
|
SPR Therapeutics, Inc.
SPR Therapeutics and the SPRINT PNS System will be featured prominently at the North American Neuromodulation Society Annual Meeting with 11 abstracts.
New SPR Therapeutics Data Presented at ASRA Pain Medicine Meeting 2023
13 nov. 2023 09h05 HE
|
SPR Therapeutics, Inc.
Three SPR Posters Accepted Including a President’s Choice Award for New Data from Randomized Controlled Trial on Total Knee Replacement Postoperative Pain
Aptean stärkt sein strategisches Netzwerk in der DACH-Region
18 juil. 2022 09h30 HE
|
Aptean Inc.
ALPHARETTA, Ga., July 18, 2022 (GLOBE NEWSWIRE) -- Aptean, ein globaler Anbieter von Softwarelösungen für geschäftskritische Prozesse, gab heute die Erweiterung seines Partnernetzwerks auf dem...
Aptean Strengthens Its Strategic Network in the DACH Region
18 juil. 2022 09h30 HE
|
Aptean Inc.
ALPHARETTA, Ga., July 18, 2022 (GLOBE NEWSWIRE) -- Today, Aptean, a global provider of mission-critical enterprise software solutions, announced the expansion of its partner network in the Swiss...